Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

53,000

Employees53,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

53,000

Employees53,000

BSX Key Statistics

Market cap

113.17B

Market cap113.17B

Price-Earnings ratio

38.52

Price-Earnings ratio38.52

Dividend yield

—

Dividend yield—

Average volume

27.87M

Average volume27.87M

High today

$76.87

High today$76.87

Low today

$74.75

Low today$74.75

Open price

$75.19

Open price$75.19

Volume

14.26M

Volume14.26M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$72.69

52 Week low$72.69

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $76.28. The company's market cap stands at 113.17B, with a P/E ratio of 38.52.

On 2026-02-17, Boston Scientific(BSX) stock moved within a range of $74.75 to $76.87. With shares now at $76.28, the stock is trading +2.0% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 14.26M, compared to an average daily volume of 27.87M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

BSX News

TipRanks 9h

Boston Scientific: EP Market Growth Validated by Medtronic, Supporting Renewed Confidence in Buy Rating

Analyst Josh Jennings from TD Cowen reiterated a Buy rating on Boston Scientific and keeping the price target at $100.00. Josh Jennings has given his Buy ratin...

TipRanks 13h

Boston Scientific price target lowered to $109 from $112 at Canaccord

Canaccord analyst William Plovanic lowered the firm’s price target on Boston Scientific (BSX) to $109 from $112 and keeps a Buy rating on the shares. The firm u...

Simply Wall St 1d

A Look At Boston Scientific Valuation As Electrophysiology Concerns Follow Strong Q4 Earnings

Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation...

Analyst ratings

97%

of 35 ratings

Buy

97.1%

Hold

2.9%

Sell

More BSX News

Simply Wall St 3d

Is It Time To Reassess Boston Scientific After Its Recent Share Price Slide

If you are wondering whether Boston Scientific's current share price still reflects its long term potential, looking closely at what you are getting for the pri...

Simply Wall St 4d

Does Boston Scientific’s 2026 Double-Digit Sales Outlook and Leadership Shift Change The Bull Case For BSX?

Boston Scientific’s fourth-quarter 2025 results, reported on February 4, 2026, showed sales rising to US$5,286 million and net income to US$672 million, alongsi...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.